Call Buying Activity Continues in BioCryst Pharma (BCRX), Targeting Upside in Shares Through July -Susquehanna

Susquehanna options strategist Alison Edwards notes call buying activity in BioCryst Pharma (NASDAQ: BCRX), as investors bought ~12k July 9 calls, adding to roughly 20K of the calls bought since early last week. A position of about 30k calls gives investors the right to buy ~3 mln shares if the shares nearly double current levels in mid-July.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Synaptics (SYNA) call put ratio 1 call to 1.3 puts after On Semi (ON) acquiring in a $7B all-stock transaction
• ON Semiconductor (ON) call put ratio 1 call to 1.5 puts after acquiring Synaptics (SYNA)